Detrol Compliance Claim Based On Tolerability Data Challenged By FDA
Executive Summary
The tolerability profile of Pharmacia's overactive bladder treatment Detrol is not sufficient evidence to support patient compliance claims, FDA's Division of Drug Marketing, Advertising & Communications indicated in a Dec. 7 letter to the company.